Form 4: CervoMed Inc. Executive Acquires Stock Options
SEC Filing
Kelly Blackburn, SVP of Clinical Development at CervoMed Inc., reports the acquisition of stock options.
Summary
- Kelly Blackburn, SVP of Clinical Development at CervoMed Inc., filed a Form 4 on February 14, 2025, reporting a transaction.
- On February 4, 2025, Blackburn acquired stock options for 27,000 shares of CervoMed Inc. common stock at an exercise price of $2.30.
- The options vest in 36 equal monthly installments starting February 28, 2025, and expire on February 4, 2035.
- Following the transaction, Blackburn directly owns derivative securities for 27,000 shares.
Sentiment
Score: 5
Explanation: Neutral sentiment as it's a standard regulatory filing about stock option grants.
Positives
- The acquisition of stock options by a key executive could signal confidence in the company's future performance.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders.
Key Dates
| Date | Description |
|---|---|
| 02/04/2025 | Date of stock option transaction |
| 02/14/2025 | Date of Form 4 filing |
| 02/28/2025 | Vesting start date |
| 02/04/2035 | Expiration date of stock options |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.